Arrow Mark Colorado Holdings LLC Orchard Therapeutics PLC Transaction History

Arrow Mark Colorado Holdings LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$5.75 - $11.99 $6.02 Million - $12.6 Million	-1,047,513 Reduced 70.38%	440,801 $2.65 Million
Q1 2020 May 15, 2020	BUY	$5.65 - $15.71 $1.02 Million - $2.82 Million	179,717 Added 13.73%	1,488,314 $11.2 Million
Q4 2019 Feb 14, 2020	BUY	$10.15 - $15.58 $4.83 Million - $7.42 Million	476,168 Added 57.2%	1,308,597 $18 Million
Q3 2019 Nov 14, 2019	BUY	$11.88 - $16.72 $1.41 Million - $1.98 Million	118,600 Added 16.61%	832,429 $9.89 Million
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.63 $16,341 - $25,539	1,238 Added 0.17%	713,829 $9.99 Million
Q1 2019 May 15, 2019	BUY	$12.01 - $19.49 $838,898 - $1.36 Million	69,850 Added 10.87%	712,591 $12.7 Million
Q4 2018 Feb 14, 2019	BUY	$12.4 - $18.7 $7.97 Million - $12 Million	642,741 New	642,741 $10.1 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.